Clinical trials: ACE Inhibitor-Induced Angioedema
- Condition ACE Inhibitor-Induced Angioedema
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
ACE Inhibitor Induced Angioedema
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
A double-blind, randomized, controlled trial comparing the safety and effectiveness of conventional therapy with ecallantide to conventional therapy with placebo.
- Trial name
- NCT01343823
- Testing
- ecallantide 60 mg, ecallantide 30 mg, ecallantide 10 mg
- Where
- 39 sites in United States
- Volunteers
- 79 people
- Sponsor
- Shire